Original language | English |
---|---|
Pages (from-to) | 796-799 |
Number of pages | 4 |
Journal | Cancer Communications |
Volume | 41 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2021 |
Externally published | Yes |
Bibliographical note
Funding Information:Canxia Shi is supported by a scholarship from the China Scholarship Council [CSC number: 201806170057]. This work was supported by a grant from the European Research Council (ERC CoG 818715, SECRETE‐HF). Further support was obtained from grants from the Netherlands Heart Foundation (CVON SHE‐PREDICTS‐HF, grant 2017‐21; CVON RED‐CVD, grant 2017‐11; CVON PREDICT2, grant 2018‐30; and CVON DOUBLE DOSE, grant 2020B005), and by a grant from the leDucq Foundation (Cure PhosphoLambaN induced Cardiomyopathy (Cure‐PLaN). Dr. Meijers is supported by the Mandema‐Stipendium of the Junior Scientific Masterclass 2020‐10, University Medical Center Groningen. We would like to thank Tim R. Eijgenraam for his experimental assistance.